Lip filler study shows promise for chinese patients
NCT ID NCT05342753
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested Restylane Kysse, a hyaluronic acid gel, for making lips fuller in 22 Chinese adults. Participants received injections, and doctors measured lip fullness using a standard scale. The goal was to see if the treatment was safe and effective for lip augmentation.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Restylane Kysse (hyaluronic acid injectable gel)
- What this could lead to
- If successful, this could provide a safe and effective option for lip augmentation in Chinese individuals.
- What could go wrong
- This is a small, completed study with only 22 participants. Results may not apply to everyone, and risks like swelling or bruising are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
22 people
The number who actually took part.
- Started
-
Jun 2022
- Finished
-
Nov 2024
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
22 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Participants willing to comply with the requirements of the study and providing a signed written informed consent * Ability to adequately understand the verbal explanations and the written subject information provided in English * Subjects seeking augmentation therapy for the lips * Adult males or non-pregnant, non-breastfeeding females, 22 years of age or older with both biological parents of full Chinese descent Exclusion Criteria: * Known/previous allergy or hypersensitivity to any injectable hyaluronic acid (HA) gel or to gram-positive bacterial proteins * Previous use of any permanent (non-biodegradable) or semipermanent (e.g., calcium hydroxylapatite or poly-L-lactic acid) facial tissue augmentation therapy, lifting threads, permanent implants or autologous fat below the level of the lower orbital rim. * Previous use of any HA-based or collagen-based biodegradable facial tissue augmentation therapy below the level of the lower orbital rim within 12 months prior to the baseline visit. * Previous facial surgery, within 6 months, below the level of the lower orbital rim * Previous surgery to the upper or lower lip, lip piercing or tattoo, or history of facial trauma. * Participation in any interventional clinical study within 30 days of screening
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Lip augmentation are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Galderma Research Site
Los Angeles, California, 94538, United States
-
Galderma Research Site
Vista, California, 92083, United States
-
Galderma Research Site
Ardmore, Pennsylvania, 19003, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.